The Role of Willingness of Participation in Cardiology Trials on the Survival of Patients

Semmelweis University

Status: Unknown

Conditions: Chronic Heart Failure; Myocardial Infarction

Treatments: Drug: Optimal medical therapy

Study type: Observational

Funder types: Other

Identifiers

NCT03840499

Study survival - v. 1.0

Details and patient eligibility

About

It has been shown retrospectively that participation and even the willingness improves the survival of patients after myocardial infarction or heart failure. We aimed to prospectively analyse the role of participation in cardiology trials on the survival of patients in a high volumen tertiary center.

Enrollment: 400 estimated patients

Sex: All

Ages: 18 to 85 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Hospitalisation due to acute myocardial infarction, and or heart failure
• Singed informed consent

Exclusion criteria

• Previous participation in any clinical study
• Haemodinamically instable, shock, intubation
• Pregnancy, breast feeding

Trial design

400 participants in 2 patient groups

Willing to participate in clinical study

Treatment:

Drug: Optimal medical therapy

Not-willing to participate in clinical study

Treatment:

Drug: Optimal medical therapy